White Paper

PDF cover

Orphan Drug Summit: Briefing Paper

ICER’s briefing paper seeks to understand the commercial, regulatory, and reimbursement environments for rare drug development, and compares methods used by academic researchers and international agencies to evaluate the long-term value of drugs for rare conditions.


View All Materials on this Topic or Go Back to View More Materials